Pfizer Pharmaceuticals - Search News

Starboard Takes $1B Stake In Pfizer

The Motley Fool on MSN · 26m

As a Billionaire Activist Takes a Stake, Is Now the Time to Buy Pfizer Stock?

Shares of Pfizer (NYSE: PFE) have been stuck in the mud since December 2022, with its shares down more than 45% over that stretch. Despite its underwhelming performance, many individual investors are attracted to the drug giant's robust dividend,

BioSpace · 19h

Activist Investor Starboard Carves $1B Stake in Pfizer, Enlists Former CEO for Help

Pfizer in recent months has implemented aggressive cost-cutting measures to help it weather the steep decline in sales of its COVID-19 products.

Activist investor takes $1B stake in Pfizer, aims to turn around company

Citing people familiar with the matter, The Journal reported that Starboard approached former Pfizer CEO Ian Read and CFO Frank D’Amelio to assist in its plans.

Pfizer, GSK

Pfizer wins bid to invalidate 2 GSK patents relating to RSV vaccine

London: Pfizer recently achieved a significant legal victory by winning bid in a London court to invalidate two patents held by GlaxoSmithKline (GSK) that are related to a vaccine for

Pfizer, BioNTech win bid to invalidate CureVac's UK COVID vaccine patents

Pfizer and its German partner BioNTech on Tuesday won their attempt to invalidate two of rival CureVac's patents at London's High Court.

Pfizer Wins London Court Battle, GSK's Respiratory Syncytial Virus Vaccine Patents Invalidated

Pfizer Inc. (NYSE:PFE) stock is trading higher with a session volume of 31.16 million as per data from Benzinga Pro. Activist investor Starboard Value has invested approximately $1 billion in Pfizer as the pharmaceutical giant grapples with a downturn in demand for COVID-19 vaccines and treatments.

13h

Pfizer CEO plans to meet activist investor Starboard Value, FT reports

Pfizer CEO Albert Bourla plans to meet activist investor Starboard Value, the Financial Times reported on Tuesday, citing ...

FiercePharma14h

Pfizer, bracing for Hurricane Milton, pledges aid to emergency services and health support

Is your company bracing for Milton or working to provide aid in anticipation of the storm? | Pfizer—which opened a global hub ...

12hon MSN

Why Pfizer Will Find It Hard to Appease Its Activist Investor

The drugmaker has cut costs already and has no coming product approvals or research that could offer a quick lift.

1don MSN

Pfizer Stock Rises After It Gets an Activist. What Starboard’s Track Record With Pharma Tells Us.

Starboard has approached two former Pfizer executives, Ian Read and Frank D’Amelio, to assist in its efforts, and they have ...

FierceBiotech12h

'Ongoing challenges' force Pfizer to scrap oral RSV med from ReViral buyout

In another blow to its $525 million buyout of ReViral, Pfizer has ended development of sisunatovir, an oral inhibitor ...

13h

Pfizer is said to have dropped RSV candidate from pipeline

Pfizer (PFE) discontinues development of experimental RSV therapy sisunatovir from pipeline in a blow for its $525M ...

18h

Pfizer CEO’s job is at risk. A shot of discipline could help.

As activist Starboard teams up with former Pfizer executives, the pharma giant’s lack of focus is in the spotlight.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results